Document:

Exhibit 10.22

Consulting
                                         AgreementThis consulting agreement (the "Agreement") is made and entered on this day
                                         2/11/20 (the "Effective Date") by and between Robert L. Hymers III (hereinafter referred
                                         to as the "Consultant") and Electromedical Technologies, Inc. (hereinafter referred to
                                         as the "Client" or "ELCQ").1. ServicesThe Consultant will provide strategic business
                                         and business services to the Client, which may include:• Financial Consulting assistance
                                         with review of quarterly and annual filings with OTC Markets • Corporate Governance
                                         and Compliance • Communication and coordination of document transfers to auditors
                                         and review • Assistance with negotiation deals and review and drafting of corresponding
                                         agreements • Communication with SEC attorney to complete resolutions and regulatory
                                         filingsThe scope of services will be subject to change from time to time as agreed to
                                         between the Consultant and the Client. The Consultant will also provide briefings, updates
                                         and other forms of communication to keep the Client informed regarding the progress of
                                         the work.The services will be rendered from the Consultant's location and/or the Client's
                                         location subject to change as necessary to properly service the Client. The Consultant
                                         will perform the services in a competent and professional manner. The Consultant will
                                         comply with applicable laws. The Consultant shall be responsible for all taxes on any
                                         compensation.2. Compensation and Reimbursement of ExpensesThe Client agrees to pay the
                                         Consultant a fixed fee of two hundred thousand (200,000) common shares for the services
                                         provided. This fee shall cover 12 months of services pursuant to Section 3 of this Agreement.
                                         The total amount owed per this agreement shall be deemed earned in full upon the execution
                                         of this agreement (i.e., February 11, 2020) and shall not vest over time. For purposes
                                         of this agreement, the shares are valued at $.30 per share. The Company shall register
                                         these shares on a best efforts basis on its next registration statement (Form S1) to
                                         be filed with the Commission.The Consultant will maintain adequate documentation and
                                         records to support all costs1

    	 

    	 

    

 

invoiced
                                         to the Client including receipts for travel related expenses however, such expenses must
                                         be approved by the Client prior to being incurred by Consultant.Payments made by the
                                         Client to the Consultant will not deduct any taxes and the Client will provide the Consultant
                                         with IRS Form 1099 at the end of each calendar year. For purposes of issuing IRS Form
                                         1099, the Consultant will provide a social security number upon execution of his agreement.The
                                         shares of Common Stock provided for a compensation to Consultant may not be sold or transferred
                                         unless:(i) such shares are sold pursuant to an effective registration statement under
                                         the Act or (ii) the Consultant or its transfer agent shall have been furnished with an
                                         opinion of counsel (which opinion shall be in form, substance and scope customary for
                                         opinions of counsel in comparable transactions) to the effect that the shares to be sold
                                         or transferred may be sold or transferred pursuant to an exemption from such registration
                                         (iii) such shares are sold or transferred pursuant to Rule 144 under the Act (or a successor
                                         rule) ("Rule 144").The certificate for shares of Common Stock has not been so included
                                         in an effective registration statement or that has not been sold pursuant to an effective
                                         registration statement or an exemption that permits removal of the legend, shall bear
                                         a legend substantially in the following form, as appropriate:"NEITHER THE ISSUANCE AND
                                         SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH
                                         THESE SECURITIES ARE EXERCISABLE HA VE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
                                         AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR
                                         SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION
                                         STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN
                                         OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE
                                         FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO
                                         RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY
                                         BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT
                                         SECURED BY THE SECURITIES."3. Term and TerminationThis agreement will commence on the
                                         effective date set forth and continue for a period of twelve months from the effective
                                         date unless terminated earlier. Either party may terminate this agreement at any time
                                         upon thirty-day (30) notification. The2

    	 

    	 

    

 

Client
                                         may at its option agree to renew, extend and revise this agreement prior to its expiration.4.
                                         Confidential InformationBoth parties acknowledge that there is an exchange of confidential
                                         and proprietary information associated with this agreement. Confidential and proprietary
                                         information may include documents, communications, plans, processes, formulations, data,
                                         know­ how, financial information, techniques, methods, customers, suppliers, partners,
                                         patents, trademarks, designs, and other forms of tangible or intangible artifacts owned
                                         by the Client. Confidential and proprietary information does not include information
                                         within the public domain, information that has been publicly known prior to the execution
                                         of this agreement, or information that the Consultant developed independent of any confidential
                                         information.The Consultant will not divulge, disseminate, publish or otherwise disclose
                                         any information without the prior consent of the Client. The Consultant will not use
                                         any information for purposes other than the performance of services described in this
                                         agreement. The Client agrees to not disclose confidential information to the Consultant
                                         except to the extent that the Consultant requires this information to fulfill the obligations
                                         within this agreement.If the Client has any concerns over the sharing of sensitive information
                                         and requires additional control measures, the Consultant will establish secured means
                                         of information sharing that are mutually agreeable to both parties. These control measures
                                         may include restricting who can copy, print, or change documents during the course ofthe
                                         engagement.5. IndemnificationNot withstanding other provisions of this agreement, the
                                         Client shall indemnify, defend and hold harmless the Consultant against claims, liabilities,
                                         damages, losses or other obligations, which may arise from this agreement.6. Relationship
                                         of PartiesThe parties agree that this agreement creates an independent contractor relationship,
                                         not an employment relationship. Neither party is, nor shall claim to be, a legal agent,
                                         representative, partner, or employee of the other, and neither shall have the right or
                                         authority to contract in the name of the other, nor shall it assume or create any obligations,
                                         debts, accounts or liabilities for the other.7. Role of the ConsultantThe Consultant
                                         will not make management decisions on behalf of the Client. The role of 3

    	 

    	 

    

 

the
                                         Consultant shall be advisory in nature with no perceived conflicts of interest prior
                                         to, during or after the engagement with the Client. This role will also extend to any
                                         third parties that the Consultant may use during the course of the engagement.8. Reliance
                                         on Client Provide InformationRegarding any information or material that the Company furnishes
                                         to Consultant or any other entity in connection with this Agreement, the Company acknowledges
                                         and confirms that (i) Consultant will use and rely on such information and material without
                                         independently verifying the same, (ii) Consultant does not assume responsibility for
                                         the accuracy or completeness of any of the information or material, (iii) Consultant
                                         will not make any appraisal, evaluation or independent determination regarding such information
                                         or material or the Company and (iv) Consultants shall not have any liability in connection
                                         with such information or material. The Company represents to Consultant that the information
                                         and material to be furnished by the Company, when delivered, will be true, complete and
                                         correct in all material respects and will not contain any material misstatement of fact
                                         or omit to state any material fact necessary to make the statements contained therein
                                         not misleading. The Company shall promptly notify Consultants if it learns of any material
                                         inaccuracy or misstatement in, or material omission from, any information or material
                                         delivered to Consultant.9. Quality Assurance and ControlIn an effort to ensure that the
                                         Consultant provides high quality work, the Client will assign the CEO of the Client company
                                         to review and approve the work of the Consultant. In the event that the Consultant uses
                                         a third party, the Consultant is responsible for the quality of the work delivered by
                                         the third party.10. Non-Agent of ClientIt is understood that Consultant is not acting
                                         as agent or fiduciary of, and have no liabilities to, the equity holders of the Company
                                         or any other third party in connection with this Agreement or any introductions, services
                                         or transactions hereunder, all of which liabilities are expressly waived.11. Governing
                                         LawThis Agreement shall be governed by and interpreted in accordance with the laws of
                                         the state of California applicable to agreements negotiated, executed and to be performed
                                         in the state, without regard to the choice or conflicts of law rules or principles of
                                         that state. The parties hereto hereby consent to the jurisdiction of the state courts
                                         located in Los Angeles, California over the parties and any disputes, claims, actions,
                                         suits and4

    	 

    	 

    

 

proceeding
                                         relating to this agreement or the transactions contemplated herein.12. Entire AgreementThis
                                         agreement represents the entire understanding of the parties superseding all prior agreements,
                                         understandings and discussions whether conveyed orally or in writing, and there are no
                                         other warranties, commitments, understandings or representations with respect to this
                                         agreement. I represent that I have the authority to enter into this agreement:Consultant
                                         ClientXName: Robert L Hymers III Name: Matthew Wolfson Title: President and CEO Electromedical
                                         Technologies, Inc.5

    	 

    	 

    

 

SPECIAL
                                         MEETING & RESOLUTION OF THE DIRECTORS ELECTROMEDICAL TECHNOLOGIES, INC. A Delaware
                                         CorporationThe undersigned, being all the Directors of Electromedical Technologies, Inc.,
                                         a Delaware Corporation (the "Company"), hereby adopt the following recitals and resolutions
                                         after the holding of a Special Meeting of the Board of Directors pursuant to the Company's
                                         By Laws, effective as of February 11,2020, the Directors hereby waiving all notice of,
                                         and the holding of, a meeting of the directors to act upon such matters and resolutions,
                                         pursuant to the Delaware Corporate Law and the Company's By-Laws. Notice of the Special
                                         Meeting having been waived verbally by the Directors present at the Special Meeting,
                                         a quorum was found to be present sufficient to conduct business.RECITALSWHEREAS, on February
                                         11, 2020, the Company entered into a consulting agreement with Robert L.Hymers III.WHEREAS,
                                         as consideration for the services rendered by Mr. Hymers, the Company agreed to issue
                                         him 200,000 shares of its common stock at the price of$.30 per share (total value of$60,000).
                                         WHEREAS, for good cause appearing, the Company HEREBY RESOLVES: to issue Robert L. Hymers
                                         III 200,000 shares of the Company's fully paid and non- assessable common stock, as follows:Robert
                                         L. Hymers III; address: 520 S. Grand Ave, Suite 320, Los Angeles, CA 90071; SSN ###-##-####,RESOLVED
                                         FURTHER, that the appropriate Officers of the Company be, and they hereby are, authorized
                                         and empowered to execute such documents, take such steps and perform such acts as, in
                                         their judgment, may be necessary or convenient in carrying out the foregoing resolutions
                                         consistent with the Company's By Laws, including placing this Resolution in the appropriate
                                         Books and Records of the Company, and that any such documents executed or acts taken
                                         by them shall be conclusive evidence of authority in so doing.IN WITNESS WHEREOF, the
                                         undersigned have executed this Resolution as of date first written above.ALL DIRECTORS
                                         OF ELECTROMEDICAL TECHNOLOGIES, INC.President, CE , irector Electromedical Technologies,
                                         Inc.Page 1 of 1Exhibit 10.25

 

 

CONSENT ACTION OF THE BOARD OF DIRECTORS OF ELECTROMEDICAL TECHNOLOGIES,
INC. The undersigned, Matthew N. Wolfson, being the sole director of Electromedical Technologies, Inc., a Delaware corporation,
(the "Company"), hereby unanimously consent to the following actions taken on Company on October 25, 2019. RESOLVED:
Due to a mathematical error on the part of the Company, to issue lakovos Tsakalidis ("Tsakalidis") an additional 7,567
shares of the Company's restricted common stock in full and complete satisfaction of any and all claims which Tsakalidis may have
against the Company pursuant to that certain Promissory Note by and between Tsakalidis and the Company dated December 31, 2015.
The shares are valued at $0.71 per share. RESOLVED: That the Company's transfer agent, Pacific Stock Transfer, is hereby authorized
to issue the foregoing shares to Tsakalidis at the following address: 6940 E. Double Tree Ranch Rd., Paradise Valley, AZ 85253.
There being no further business requiring board action or consideration, on motion duly made, and carried, the meeting was adjourned.
Matthew N Wolfson Sole Director

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00309-of-00352.parquet"}]]